10.1002/anie.201710940
Angewandte Chemie International Edition
COMMUNICATION
[14] Further selected examples: a) G. Lipowsky, N. Miller, G.Helmchen,
Angew. Chem. Int. Ed. 2004, 43, 4595; b) T. Graening, J. F. Hartwig, J.
Am. Chem. Soc. 2005, 127, 17192; c) H. He, X.-J. Zheng, Y. Li, L.-X.
Dai, S.-L. You, Org. Lett. 2007, 9, 4339; d) W.-B. Liu, H. He, L.-X. Dai,
S.-L. You, Org. Lett. 2008, 10, 1815; e) J. Y. Hamilton, D. Sarlah, E. M.
Carreira, J. Am. Chem. Soc. 2013, 135, 994; f) M. Chen, J. F. Hartwig,
Angew. Chem. Int. Ed. 2014, 53, 12172; g) M. Chen, J. F. Hartwig, J.
Am. Chem. Soc. 2015, 137, 13972.
Acknowledgements
This work was financially supported by the Deutsche
Forschungsgemeinschaft (DFG, PE 818/4-2).
Keywords: heterocycle • isoxazolinone • phosphoramidite •
quaternary stereocenter • regioselectivity
[15] Helmchen reported the first examples of iridium phosphoramidite
catalysts bearing dbcot ligands as much more stable alternative to the
corresponding cod complexes. For the initial study and further
examples see: a) C2: S. Spiess, C. Welter, G. Franck, J.-P. Taquet, G.
Helmchen, Angew. Chem. Int. Ed. 2008, 47, 7652; b) J. Qu, G.
Helmchen, Acc. Chem. Res. 2017, 50, 2539; c) C1: J. A. Raskatov, M.
Jäkel, B. F. Straub, F. Rominger, G. Helmchen Chem. Eur. J. 2012, 18,
14314; d) C3 & C5: K.-Y. Ye, L.-X. Dai, S.-L. You, Org. Biomol. Chem.
2012, 10, 5932.
[1]
Representative examples: a) Anti-obesity effect: B. Kafle, N. G. Aher, D.
Khadka, H. Park, H. Cho, Chem. Asian J. 2011, 6, 2073; b) anti-
androgenic activity towards tumor cells: T. Ishioka, A. Kubo, Y. Koiso, K.
Nagasawa, A. Itai, Y. Hashimoto, Bioorg. Med. Chem. 2002, 10, 1555;
c) T. Ishioka, A. Tanatani, K. Nagasawa, Y. Hashimoto, Bioorg. Med.
Chem. Lett. 2003, 13, 2655; d) anti-cancer and antibacterial activity: M.
S. Chande, R. S. Verma, P. A. Barve, R. R. Khanwelkar, R. B. Vaidya,
K. B. Ajaikumar, Eur. J. Med. Chem. 2005, 40, 1143; e) protein kinase
C inhibitors: J. P. Demers, W. E. Hageman, S. G. Johnson, D. H.
Klaubert, R. A. Look, J. B. Moore, Bioorg. Med. Chem. Lett. 1994, 4,
2451.
[16] For the corresponding cyclooctadiene (cod) derivatives, see e.g.: a) cod
derivatives of C1, C2, C3: X. Jiang, J. J. Beiger, J. F. Hartwig, J. Am.
Chem. Soc. 2017, 139, 87; b) cod derivative of C2: W. Chen, J. F.
Hartwig, J. Am. Chem. Soc. 2013, 135, 2068; c) cod derivative of C4:
B. Bartels, C. García-Yebra, G. Helmchen, Eur. J. Org. Chem. 2003,
1097; b) cod derivative of C5: W-B. Liu, C. Zheng, C.-X. Zhuo, L.-X.
Dai, S.-L. You, J. Am. Chem. Soc. 2012, 134, 4812.
[2]
[3]
a) S. Batra, M. Seth, A. P. Bhaduri, J. Chem. Res (S) 1992, 139; b) S.
Batra, M. Seth, A. P. Bhaduri, J. Chem. Res (M) 1992, 1025.
a) K. Okamoto, T. Oda, S. Kohigashi, K. Ohe, Angew. Chem. Int. Ed.
2011, 50, 11470; Angew. Chem. 2011, 123, 11672; b) K. Okamoto, T.
Shimbayashi, E. Tamura, K. Ohe, Chem. Eur. J. 2014, 20, 1490; c) K.
Okamoto, T. Shimbayashi, M. Yoshida, A. Nanya, K. Ohe, Angew.
Chem. Int. Ed. 2016, 55, 7199; Angew. Chem. 2016, 128, 7315.
S. Rieckhoff, T. Hellmuth, R. Peters, J. Org. Chem. 2015, 80, 6822.
S. Rieckhoff, M. Titze, W. Frey, R. Peters, Org. Lett. 2017, 19, 4436.
a) W.-T. Meng, Y. Zheng, J. Nie, N.-Y. Xiong, J.-A. Ma, J. Org. Chem.
2013, 78, 559; b) H. Zhang, B. Wang, L. Cui, X. Bao, J. Qu, Y. Song,
Eur. J. Org. Chem. 2015, 2143.
[17] The corresponding cyclooctadiene (cod) complexes were also
investigated and gave results that were comparable to the dbcot
complexes with usually somewhat lower enantioselectivity. For instance,
the corresponding experiment to Table 1, entry 1 using a cod spectator
ligand gave 74% product and an er = 85.5:14.5. We preferred to use
the dbcot complexes, because reproducibility with the cod complexes
was contrary to the dbcot complexes not satisfying, in particular after
storage of the catalysts for some weeks.
[18] CCDC-1574308 (catalyst C1, (R3=pMe-C6H4)), CCDC-1574318 (4jH),
CCDC-1574319 (3dA) contain the supplementary crystallographic data
for this paper. These data can be obtained free of charge from The
[4]
[5]
[6]
[7]
a) Quaternary Stereocenters: Challenges and Solutions for Organic
Synthesis (Eds.: J. Christoffers, A. Baro), Wiley-VCH: Weinheim,
Germany, 2005; b) J. Christoffers, A. Baro, Adv. Synth. Catal. 2005,
347, 1473.
Cambridge
Crystallographic
Data
Centre
via
[8]
[9]
T. Hellmuth, W. Frey, R. Peters, Angew. Chem. Int. Ed. 2015, 54,
2788; Angew. Chem. 2015, 127, 2829.
[19] a) W.-B. Liu, N. Okamoto, E. J. Alexy, A. Y. Hong, K. Tran, B. M. Stoltz,
J. Am. Chem. Soc. 2016, 138, 5234; b) J. Liu, C.-G. Cao, H.-B. Sun, X.
Zhang, D. Niu, J. Am. Chem. Soc. 2016, 138, 13103; c) M. Kawatsura,
H. Tsuji, K. Uchida, T. Itoh, Tetrahedron 2011, 67, 7686.
See, for instance: a) ref. 1; b) M. Atfani, W. D. Lubell, J. Org. Chem.
1995, 60, 3184; c) F. De Sarlo, Tetrahedron 1967, 23, 831; d) R.
Jacquier, C. Petrus, F. Petrus, J. Verducci, Bull. Soc. Chim. Fr. 1970, 7,
2690.
[20] M. J. S. Gomes, L. F. V. Pinto, P. M. C. Glória, H. S. Rzepa, S.
Prabhakar, A. M. Lobo, Chem. Cent. J. 2013, 7, 94.
[10] M. Moreno-Manas, M. Pérez, R. Pleixats, Tetrahedron 1994, 50, 515.
[11] Recent reviews: a) W.-B- Liu, J.-B. Xia, S.-L. You, Top. Organomet.
Chem. 2012, 38, 155; b) P. Tosatti, A. Nelson, S. P. Marsden, Org.
Biomol. Chem. 2012, 10, 3147; c) J. F. Hartwig, M. J. Pouy, Top.
Organomet. Chem. 2011, 34, 169; d) J. F. Hartwig, L. M. Stanley, Acc.
Chem. Res. 2010, 43, 1461; e) G. Helmchen in Iridium Complexes in
Organic Synthesis (Eds.: L. A. Oro, C. Claver), Wiley-VCH, Weinheim
2009, pp. 211-250; f) G. Helmchen, A. Dahnz, P. Dübon, M. Schelwies,
R. Weihofen, Chem. Commun. 2007, 675.
[21] W. Chen, J. F. Hartwig, J. Am. Chem. Soc. 2012, 134, 15249.
[22] The rearrangement of 4aH was also studied in the presence of
Pd(OAc)2 (5 mol%) in DMF. The following conversions were found after
24 h: 97%@110 °C; 77%@100 °C (full conversion after 48 h);
55%@90 °C.
[23] Selected reviews on sigmatropic rearrangements: a) S. Jautze, R.
Peters, In Science of Synthesis: Stereoselective Synthesis, Evans, P.
A., Ed.; Thieme: Stuttgart, 2011; Vol. 3, Chapter 3.10, pp 443–467; b) U.
Nubbemeyer, Synthesis 2003, 961.
[12] Early studies on Ir-catalyzed allylic substitutions: a) R. Takeuchi, M.
Kashio, Angew. Chem. Int. Ed. 1997, 36, 263; b) J. P. Janssen, G.
Helmchen, Tetrahedron. Lett. 1997, 38, 8025; c) R. Takeuchi, M.
Kashio, J. Am. Chem. Soc. 1998, 120, 8647; d) B. Bartels, C. Garciá-
Yebra, F. Rominger, G. Helmchen, Eur. J. Inorg. Chem. 2002, 2569; e)
T. Ohmura, J. F. Hartwig, J. Am. Chem. Soc. 2002, 124, 15164; f) C. A.
Kiener, C. Shu, C. Incarvito, J. F. Hartwig, J. Am. Chem. Soc. 2003,
125, 14272.
[24] For Pd-catalyzed [3,3]-rearrangements, see e.g.: a) H. Nakamura, Y.
Yamamoto, in Handbook of Organopalladium Chemistry for Organic
Synthesis 2002, vol. 2, pp 2919-2934; b) K. Akiyama, K. Mikami,
Tetrahedron Lett. 2004, 45, 7217; c) K. N. Fanning, A. G. Jamieson, A.
Sutherland, Curr. Org. Chem. 2006, 10, 1007; d) R. Peters, D. F.
Fischer, S. Jautze, Top. Organomet. Chem. 2011, 33, 139; e) J. M.
Bauer, W. Frey, R. Peters, Angew. Chem. Int. Ed. 2014, 53, 7634; f) R.
Peters, Z.-q. Xin, F. Maier, Chem. Asian J. 2010, 5, 1770.
[13] Very recently Hartwig et al. reported a detailed computational study
which suggested that a number of weak interactions including CH...O
hydrogen bonds contribute to the preference for the branched
regioisomers using iridacycle catalysts: S. T. Madrahimov, Q. Li, A.
Sharma, J. F. Hartwig, J. Am. Chem. Soc. 2015, 137, 14968.
This article is protected by copyright. All rights reserved.